Posts filed under Drugs

Imported Medication Might be Fake

Photo source:  Pennside Partners Ltd

Photo source: Pennside Partners Ltd

Sens. Chuck Grassley, R-Iowa, and Amy Klobuchar, D-Minn., recently introduced a bill that would permit Americans to import pharmaceuticals from Canada. The two lawmakers believe their bill will reduce drug costs. But at what cost?

The bill would instead expose patients to potentially dangerous counterfeit drugs. Lawmakers would be wise to vote against it.

Read more: GUEST COMMENTARY: Imported medication might be fake

Posted on March 14, 2019 and filed under Drugs.

HIGGINS: Give Law Enforcement Resources to Respond to Drug Crisis

Photo source: YouTube

Photo source: YouTube

Per Facebook, Rep. Clay Higgins had the following to say during a recent committee meeting on the drug crisis:

Law enforcement professionals tasked with securing our borders don't need DC bureaucrats or politicians, who've never worn a badge, to tell them what their mission is. All they need is for Congress to provide the resources that they have clearly and properly requested.

Posted on March 8, 2019 and filed under Clay Higgins, Drugs.

Conservatives Oppose HHS International Pricing Index for Medicare Part B Drugs

Photo source: BBC

Photo source: BBC

In a letter to the Department of Health and Human Services, ATR and 56 other conservative groups and activists expressed opposition to HHS’s “International Pricing Index” (IPI) payment model for drugs administered under Medicare Part B.

Click here to read the full letter.

Read more:  Conservatives Oppose HHS International Pricing Index for Medicare Part B Drugs

Posted on March 7, 2019 and filed under Drugs.

Poison Pill: Importing Foreign Drug Price Controls

Photo source: Bloomberg  

Photo source: Bloomberg  

“As the title of this paper, "Poison Pill: Importing Foreign Drug Price Controls," suggests, both the regulatory and legislative proposals to index domestic drug prices to foreign prices run into the same serious economic issues. However one serious flaw trumps all others. The focus of the paper is on the fact that governments cannot effectively set efficient prices.“

Read more:  Poison Pill: Importing Foreign Drug Price Controls

Posted on March 4, 2019 and filed under Drugs.

Canadian shelves ‘would run dry’ if U.S. imports drugs

Importing prescription drugs from Canada has long been seen as an easy solution to skyrocketing drug prices for U.S. patients.

But now that President Donald Trump and Democrats are pushing to make those cross-border sales legal, Canadian health experts are issuing a dire warning: It could destroy Canada's drug market.

Read more: Canadian shelves ‘would run dry’ if U.S. imports drugs

Posted on February 22, 2019 and filed under Drugs.

Opinion: Grassley-Klobuchar proposal ushers in dangerous counterfeit drugs

Photo source: Axios

Photo source: Axios

On cost, the Grassley-Klobuchar would yield negligible savings at best. If the entire nation legalized drug importation, number crunchers at the Department of Health and Human Services predict that American drug spending would decrease by less than 1 percent.

On safety, the bill encourages prescription drug abuse. Legally, Canadian pharmacies can only fill scripts written by Canadian physicians. Creatively, some online pharmacies recruit local doctors to "co-sign" prescriptions for American patients. Writing a prescription for a patient one hasn't seen isn't just unethical; it invites fraud. This is especially worrisome given the rising prevalence of prescription drug misuse and abuse.

The bill also exposes Americans to dangerous counterfeits. It's estimated that 1 million people die at the hand of counterfeit drugs every year, many of which come from Canada.

Read more: Opinion: Grassley-Klobuchar proposal ushers in dangerous counterfeit drugs

Posted on February 11, 2019 and filed under Drugs.

Economists Agree: Free Markets Bring Down Prices

Photo source: Redstate

Photo source: Redstate

As the economists note, instituting price caps skews the market and “leads to shortages, squeezes the cost bubble toward some other portion of the economy, and imposes a deadweight cost on society.”

In laymen’s terms: these price controls will restrict patient access to needed drugs and reduce drug makers’ ability to invest in the research and development of new medicines.

Read more: Economists Agree: Free Markets Bring Down Prices

Posted on December 17, 2018 and filed under Drugs.

Drug-Price Controls Can Be Injurious to Your Health

Photo source: National Review

Photo source: National Review

President Trump is right to try to lower drug prices here at home. It is a travesty that other nations get access to U.S. innovation at cut-rate prices — much lower than what Americans pay. For example, the Health and Human Services Department reports that a senior who receives an eye medicine that currently costs Medicare $1,800 a month is charged only $300 a month in many other nations. A popular chemotherapy drug costs Medicare $4,700 for each treatment here in the U.S. but only $1,100 in other nations. HHS estimates that Americans pay “180 percent of what other countries pay for physician-administered drugs.” Something is seriously wrong here.

Read more: Drug-Price Controls Can Be Injurious to Your Health

Posted on December 11, 2018 and filed under Donald Trump, Drugs.

Americans for Tax Reform: Conservatives Oppose HHS International Pricing Index for Medicare Part B Drugs

Photo source: Twitter 

Photo source: Twitter 

In a letter to the Department of Health and Human Services, ATR and 56 other conservative groups and activists expressed opposition to HHS’s “International Pricing Index” (IPI) payment model for drugs administered under Medicare Part B.

Read more: Conservatives Oppose HHS International Pricing Index for Medicare Part B Drugs

Posted on December 7, 2018 and filed under Drugs, Taxes.

FDA Launches Global Crackdown on Websites Selling Illicit Opioids and Drugs

Photo source: FDA

Photo source: FDA

As part of the crackdown, called Operation Pangea XI, the FDA sent warnings to seven different networks operating 465 websites that were offering up misbranded or unapproved drugs. This is the 11th annual operation.

Some of the domains include seemingly innocuous names like bestgenericstore.com or top-meds-discounts.com.

Read more: FDA Launches Global Crackdown on Websites Selling Illicit Opioids and Drugs

Posted on November 12, 2018 and filed under Drugs.